The lung is well established as a postnatal target site for growth hormone (GH) action, given that pathophysiological states of GH excess and deficiency are both associated with impaired pulmonary function (97). The gene discussed is GH1; the disease is hyperinsulinemic hypoglycemia, familial, 4.